ClinicalTrials.govpublic full text
PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES
colorectal cancer liver metastases, liver metastases, colorectal cancer, perioperative treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834702
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.